Literature DB >> 29428973

Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway.

Melike Pekmezci1, Meredith Stevers1, Joanna J Phillips1,2, Jessica Van Ziffle1,3, Boris C Bastian1,3, Nadejda M Tsankova4, Bette K Kleinschmidt-DeMasters5, Marc K Rosenblum6, Tarik Tihan1, Arie Perry1,2, David A Solomon7,8.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29428973      PMCID: PMC6067952          DOI: 10.1007/s00401-018-1820-4

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  13 in total

1.  Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.

Authors:  Yasuhito Arai; Yasushi Totoki; Fumie Hosoda; Tomoki Shirota; Natsuko Hama; Hiromi Nakamura; Hidenori Ojima; Koh Furuta; Kazuaki Shimada; Takuji Okusaka; Tomoo Kosuge; Tatsuhiro Shibata
Journal:  Hepatology       Date:  2014-02-18       Impact factor: 17.425

2.  Multinodular and Vacuolating Neuronal Tumor: A Rare Seizure-associated Entity.

Authors:  Sahara J Cathcart; Jeffrey R Klug; Jason T Helvey; Matthew L White; Andrew P Gard; Rodney D McComb
Journal:  Am J Surg Pathol       Date:  2017-07       Impact factor: 6.394

3.  High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis.

Authors:  Noah A Brown; Larissa V Furtado; Bryan L Betz; Mark J Kiel; Helmut C Weigelin; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  Blood       Date:  2014-06-30       Impact factor: 22.113

4.  Natural history of lesions with the MR imaging appearance of multinodular and vacuolating neuronal tumor.

Authors:  Reema Alsufayan; Paula Alcaide-Leon; Lyne Noel de Tilly; Daniel M Mandell; Timo Krings
Journal:  Neuroradiology       Date:  2017-07-27       Impact factor: 2.804

5.  Multinodular and Vacuolating Neuronal Tumor of the Cerebrum: A New "Leave Me Alone" Lesion with a Characteristic Imaging Pattern.

Authors:  R H Nunes; C C Hsu; A J da Rocha; L L F do Amaral; L F S Godoy; T W Watkins; V H Marussi; M Warmuth-Metz; H C Alves; F G Goncalves; B K Kleinschmidt-DeMasters; A G Osborn
Journal:  AJNR Am J Neuroradiol       Date:  2017-07-13       Impact factor: 3.825

6.  Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis.

Authors:  Rikhia Chakraborty; Thomas M Burke; Oliver A Hampton; Daniel J Zinn; Karen Phaik Har Lim; Harshal Abhyankar; Brooks Scull; Vijetha Kumar; Nipun Kakkar; David A Wheeler; Angshumoy Roy; Poulikos I Poulikakos; Miriam Merad; Kenneth L McClain; D Williams Parsons; Carl E Allen
Journal:  Blood       Date:  2016-10-11       Impact factor: 22.113

7.  Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.

Authors:  Cassie N Kline; Nancy M Joseph; James P Grenert; Jessica van Ziffle; Eric Talevich; Courtney Onodera; Mariam Aboian; Soonmee Cha; David R Raleigh; Steve Braunstein; Joseph Torkildson; David Samuel; Michelle Bloomer; Alejandra G de Alba Campomanes; Anuradha Banerjee; Nicholas Butowski; Corey Raffel; Tarik Tihan; Andrew W Bollen; Joanna J Phillips; W Michael Korn; Iwei Yeh; Boris C Bastian; Nalin Gupta; Sabine Mueller; Arie Perry; Theodore Nicolaides; David A Solomon
Journal:  Neuro Oncol       Date:  2017-05-01       Impact factor: 12.300

8.  Multinodular and vacuolating neuronal tumors of the cerebrum: 10 cases of a distinctive seizure-associated lesion.

Authors:  Jason T Huse; Mark Edgar; John Halliday; Irina Mikolaenko; Ehud Lavi; Marc K Rosenblum
Journal:  Brain Pathol       Date:  2013-02-01       Impact factor: 6.508

9.  Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.

Authors:  Rikhia Chakraborty; Oliver A Hampton; Xiaoyun Shen; Stephen J Simko; Albert Shih; Harshal Abhyankar; Karen Phaik Har Lim; Kyle R Covington; Lisa Trevino; Ninad Dewal; Donna M Muzny; Harshavardhan Doddapaneni; Jianhong Hu; Linghua Wang; Philip J Lupo; M John Hicks; Diana L Bonilla; Karen C Dwyer; Marie-Luise Berres; Poulikos I Poulikakos; Miriam Merad; Kenneth L McClain; David A Wheeler; Carl E Allen; D Williams Parsons
Journal:  Blood       Date:  2014-09-08       Impact factor: 22.113

10.  BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors.

Authors:  Kimberly Brown Dahlman; Junfeng Xia; Katherine Hutchinson; Charles Ng; Donald Hucks; Peilin Jia; Mohammad Atefi; Zengliu Su; Suzanne Branch; Pamela L Lyle; Donna J Hicks; Viviana Bozon; John A Glaspy; Neal Rosen; David B Solit; James L Netterville; Cindy L Vnencak-Jones; Jeffrey A Sosman; Antoni Ribas; Zhongming Zhao; William Pao
Journal:  Cancer Discov       Date:  2012-07-13       Impact factor: 39.397

View more
  15 in total

1.  Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features.

Authors:  Calixto-Hope G Lucas; Javier E Villanueva-Meyer; Nicholas Whipple; Nancy Ann Oberheim Bush; Tabitha Cooney; Susan Chang; Michael McDermott; Mitchel Berger; Elaine Cham; Peter P Sun; Angelica Putnam; Hong Zhou; Robert Bollo; Samuel Cheshier; Matthew M Poppe; Kar-Ming Fung; Sarah Sung; Chad Glenn; Xuemo Fan; Serguei Bannykh; Jethro Hu; Moise Danielpour; Rong Li; Elizabeth Alva; James Johnston; Jessica Van Ziffle; Courtney Onodera; Patrick Devine; James P Grenert; Julieann C Lee; Melike Pekmezci; Tarik Tihan; Andrew W Bollen; Arie Perry; David A Solomon
Journal:  Brain Pathol       Date:  2019-11-06       Impact factor: 6.508

Review 2.  Uncommon Glioneuronal Tumors: A Radiologic and Pathologic Synopsis.

Authors:  A Vaz; M S Cavalcanti; E B da Silva Junior; R Ramina; B C de Almeida Teixeira
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-05       Impact factor: 4.966

3.  Myxoid glioneuronal tumor of the septum pellucidum and lateral ventricle is defined by a recurrent PDGFRA p.K385 mutation and DNT-like methylation profile.

Authors:  David A Solomon; Andrey Korshunov; Martin Sill; David T W Jones; Marcel Kool; Stefan M Pfister; Xuemo Fan; Serguei Bannykh; Jethro Hu; Moise Danielpour; Rong Li; James Johnston; Elaine Cham; Tabitha Cooney; Peter P Sun; Nancy Ann Oberheim Bush; Michael McDermott; Jessica Van Ziffle; Courtney Onodera; James P Grenert; Boris C Bastian; Javier E Villanueva-Meyer; Melike Pekmezci; Andrew W Bollen; Arie Perry
Journal:  Acta Neuropathol       Date:  2018-07-13       Impact factor: 17.088

4.  A multinodular and vacuolating neuronal tumor of the cerebrum (MVNT) with glioma-like appearance.

Authors:  Daniele Bagatto; Tamara Ius; Enrico Pegolo; Mauro Morassi
Journal:  Acta Neurol Belg       Date:  2020-07-06       Impact factor: 2.396

Review 5.  Emerging glioneuronal and neuronal tumors: case-based review.

Authors:  So Dug Lim; Seong Ik Kim; Jin Woo Park; Jae Kyung Won; Seung-Ki Kim; Ji Hoon Phi; Chun-Kee Chung; Seung-Hong Choi; Hongseok Yun; Sung-Hye Park
Journal:  Brain Tumor Pathol       Date:  2022-01-20       Impact factor: 3.298

6.  The genetic landscape of gliomas arising after therapeutic radiation.

Authors:  Giselle Y López; Jessica Van Ziffle; Courtney Onodera; James P Grenert; Iwei Yeh; Boris C Bastian; Jennifer Clarke; Nancy Ann Oberheim Bush; Jennie Taylor; Susan Chang; Nicholas Butowski; Anuradha Banerjee; Sabine Mueller; Cassie Kline; Joseph Torkildson; David Samuel; Aleli Siongco; Corey Raffel; Nalin Gupta; Sandeep Kunwar; Praveen Mummaneni; Manish Aghi; Philip Theodosopoulos; Mitchel Berger; Joanna J Phillips; Melike Pekmezci; Tarik Tihan; Andrew W Bollen; Arie Perry; David A Solomon
Journal:  Acta Neuropathol       Date:  2018-09-08       Impact factor: 15.887

Review 7.  The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.

Authors:  Tejus A Bale; Marc K Rosenblum
Journal:  Brain Pathol       Date:  2022-02-25       Impact factor: 7.611

8.  The genetic landscape of ganglioglioma.

Authors:  Melike Pekmezci; Javier E Villanueva-Meyer; Benjamin Goode; Jessica Van Ziffle; Courtney Onodera; James P Grenert; Boris C Bastian; Gabriel Chamyan; Ossama M Maher; Ziad Khatib; Bette K Kleinschmidt-DeMasters; David Samuel; Sabine Mueller; Anuradha Banerjee; Jennifer L Clarke; Tabitha Cooney; Joseph Torkildson; Nalin Gupta; Philip Theodosopoulos; Edward F Chang; Mitchel Berger; Andrew W Bollen; Arie Perry; Tarik Tihan; David A Solomon
Journal:  Acta Neuropathol Commun       Date:  2018-06-07       Impact factor: 7.801

9.  Oligodendrogliomas, IDH-mutant and 1p/19q-codeleted, arising during teenage years often lack TERT promoter mutation that is typical of their adult counterparts.

Authors:  Julieann Lee; Angelica R Putnam; Samuel H Chesier; Anuradha Banerjee; Corey Raffel; Jessica Van Ziffle; Courtney Onodera; James P Grenert; Boris C Bastian; Arie Perry; David A Solomon
Journal:  Acta Neuropathol Commun       Date:  2018-09-19       Impact factor: 7.801

10.  Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.

Authors:  Calixto-Hope G Lucas; Rohit Gupta; Pamela Doo; Julieann C Lee; Cathryn R Cadwell; Biswarathan Ramani; Jeffrey W Hofmann; Emily A Sloan; Bette K Kleinschmidt-DeMasters; Han S Lee; Matthew D Wood; Marjorie Grafe; Donald Born; Hannes Vogel; Shahriar Salamat; Diane Puccetti; David Scharnhorst; David Samuel; Tabitha Cooney; Elaine Cham; Lee-Way Jin; Ziad Khatib; Ossama Maher; Gabriel Chamyan; Carole Brathwaite; Serguei Bannykh; Sabine Mueller; Cassie N Kline; Anu Banerjee; Alyssa Reddy; Jennie W Taylor; Jennifer L Clarke; Nancy Ann Oberheim Bush; Nicholas Butowski; Nalin Gupta; Kurtis I Auguste; Peter P Sun; Jarod L Roland; Corey Raffel; Manish K Aghi; Philip Theodosopoulos; Edward Chang; Shawn Hervey-Jumper; Joanna J Phillips; Melike Pekmezci; Andrew W Bollen; Tarik Tihan; Susan Chang; Mitchel S Berger; Arie Perry; David A Solomon
Journal:  Acta Neuropathol Commun       Date:  2020-08-28       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.